Search This Blog

Friday, December 22, 2023

Amylyx Starts Phase 3 in Progressive Supranuclear Palsy

  Largest ever PSP clinical trial will evaluate the efficacy and safety of AMX0035 in adults with PSP compared to placebo

Trial to enroll approximately 600 participants across the U.S., Canada, Europe, and Japan

https://www.businesswire.com/news/home/20231222281941/en/

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.